Company · Public · BIOA
BioAge Labs, Inc.
Clinical-stage company that builds drug programmes from human longevity cohort data, targeting metabolic and inflammatory pathways of aging with an emphasis on preserving muscle during weight loss.
Listing
Public
Ticker
BIOA
Headquarters
Richmond, US
Founded
2015
Technology
Human-longevity-data-derived metabolic aging therapeutics
Category
Longevity thesis
If human aging cohorts identify which pathways actually track healthy survival, drug selection becomes an evidence-led rather than a model-led decision.
Programmes
- AzelapragPhase 2
Muscle preservation during obesity treatment
- Brain-penetrant NLRP3 inhibitor programmePreclinical
Neuroinflammation in aging
Reference information for research context only. It is not a rating, a valuation or investment advice. Published developments appear in the News archive.